Cancer vaccines based on the identification of genes encoding cancer regression antigens

Steven A. Rosenberg

doi:10.1016/S0167-5699(97)84664-6

Cancer vaccines based on the identification of genes encoding cancer regression antigens

Steven A. Rosenberg

Research output: Contribution to journal › Review article › peer-review

372 Scopus citations

Abstract

The adoptive transfer of tumor-infiltrating lymphocytes (TILs) can mediate the regression of metastatic melanoma in humans. The genes encoding the antigens recognized by these TILs have been cloned and characterized. Here, Steven Rosenberg reviews how these genes and gene products are being used to develop new immunotherapies for the treatment of patients with cancer.

Original language	English (US)
Pages (from-to)	175-182
Number of pages	8
Journal	Immunology Today
Volume	18
Issue number	4
DOIs	https://doi.org/10.1016/S0167-5699(97)84664-6
State	Published - Apr 1997
Externally published	Yes

ASJC Scopus subject areas

Immunology

Access to Document

10.1016/S0167-5699(97)84664-6

Cite this

@article{fbd750b86600446d8143a8fe94ed4581,

title = "Cancer vaccines based on the identification of genes encoding cancer regression antigens",

abstract = "The adoptive transfer of tumor-infiltrating lymphocytes (TILs) can mediate the regression of metastatic melanoma in humans. The genes encoding the antigens recognized by these TILs have been cloned and characterized. Here, Steven Rosenberg reviews how these genes and gene products are being used to develop new immunotherapies for the treatment of patients with cancer.",

author = "Rosenberg, {Steven A.}",

year = "1997",

month = apr,

doi = "10.1016/S0167-5699(97)84664-6",

language = "English (US)",

volume = "18",

pages = "175--182",

journal = "Immunology Today",

issn = "0167-5699",

publisher = "Elsevier Limited",

number = "4",

}

TY - JOUR

T1 - Cancer vaccines based on the identification of genes encoding cancer regression antigens

AU - Rosenberg, Steven A.

PY - 1997/4

Y1 - 1997/4

N2 - The adoptive transfer of tumor-infiltrating lymphocytes (TILs) can mediate the regression of metastatic melanoma in humans. The genes encoding the antigens recognized by these TILs have been cloned and characterized. Here, Steven Rosenberg reviews how these genes and gene products are being used to develop new immunotherapies for the treatment of patients with cancer.

AB - The adoptive transfer of tumor-infiltrating lymphocytes (TILs) can mediate the regression of metastatic melanoma in humans. The genes encoding the antigens recognized by these TILs have been cloned and characterized. Here, Steven Rosenberg reviews how these genes and gene products are being used to develop new immunotherapies for the treatment of patients with cancer.

UR - http://www.scopus.com/inward/record.url?scp=0030890836&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030890836&partnerID=8YFLogxK

U2 - 10.1016/S0167-5699(97)84664-6

DO - 10.1016/S0167-5699(97)84664-6

M3 - Review article

C2 - 9136454

AN - SCOPUS:0030890836

SN - 0167-5699

VL - 18

SP - 175

EP - 182

JO - Immunology Today

JF - Immunology Today

IS - 4

ER -

Cancer vaccines based on the identification of genes encoding cancer regression antigens

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this